HMGN OTC
Hemagen Diagnostics, Inc.
1W: +0.0%
1M: +0.0%
3M: -92.3%
YTD: +0.0%
1Y: +100.0%
3Y: +100.0%
5Y: -97.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$359K
-6.4% ▼
Capital Expenditures
$91K
-61.4% ▼
5Y CAGR: +1.2%
Free Cash Flow
-$450K
-14.3% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$147K
-338.1% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $427K | -$808K | -$156K | -$880K | -$907K |
| Depreciation & Amort. | $108K | $157K | $164K | $186K | $164K |
| Stock-Based Comp. | $25K | $53K | $42K | $47K | $48K |
| Change in Working Capital | $411K | $327K | -$197K | $270K | $288K |
| Other Non-Cash Items | -$706K | $288K | -$36K | $40K | $49K |
| Operating Cash Flow | $265K | $17K | -$183K | -$337K | -$359K |
| — Investing Activities — | |||||
| Capital Expenditures | -$368K | -$115K | -$74K | -$56K | -$91K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $210K | $210K | $35K |
| Other Investing | $184K | $262K | $41K | $3K | $35K |
| Investing Cash Flow | -$185K | $147K | $177K | $156K | -$56K |
| — Financing Activities — | |||||
| Net Debt Issuance | $39K | -$223K | -$31K | $271K | $307K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $39K | -$223K | -$31K | $271K | $307K |
| Net Change in Cash | $92K | $58K | -$5K | $62K | -$147K |
| Cash End of Period | $99K | $156K | $152K | $214K | $66K |
| Free Cash Flow | -$103K | -$98K | -$257K | -$394K | -$450K |